位置:首页 > 蛋白库 > UN93B_MOUSE
UN93B_MOUSE
ID   UN93B_MOUSE             Reviewed;         598 AA.
AC   Q8VCW4; O89077; Q3TNR9; Q710D2; Q8CIK1; Q8R3D0;
DT   07-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   03-AUG-2022, entry version 127.
DE   RecName: Full=Protein unc-93 homolog B1 {ECO:0000305};
DE            Short=Unc-93B1;
GN   Name=Unc93b1 {ECO:0000312|MGI:MGI:1859307}; Synonyms=Unc93b;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J; TISSUE=Oviduct;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=FVB/N; TISSUE=Colon, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 264-315 (ISOFORM 1).
RC   STRAIN=C57BL/6 X CBA; TISSUE=Spleen;
RA   Kollewe A.;
RT   "Cloning and characterization of mammalian homologs of unc-93 from
RT   Caenorhabditis elegans, a protein relevant for muscle contraction.";
RL   Thesis (2001), University of Hannover, Germany.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 317-434 (ISOFORM 1), AND INDUCTION.
RC   STRAIN=BALB/cJ; TISSUE=Spleen;
RX   PubMed=9798653; DOI=10.1016/s0161-5890(98)00031-5;
RA   Chu C.C., Paul W.E.;
RT   "Expressed genes in interleukin-4 treated B cells identified by cDNA
RT   representational difference analysis.";
RL   Mol. Immunol. 35:487-502(1998).
RN   [5]
RP   FUNCTION, MUTAGENESIS OF HIS-412, AND SUBCELLULAR LOCATION.
RX   PubMed=16415873; DOI=10.1038/ni1297;
RA   Tabeta K., Hoebe K., Janssen E.M., Du X., Georgel P., Crozat K., Mudd S.,
RA   Mann N., Sovath S., Goode J., Shamel L., Herskovits A.A., Portnoy D.A.,
RA   Cooke M., Tarantino L.M., Wiltshire T., Steinberg B.E., Grinstein S.,
RA   Beutler B.;
RT   "The Unc93b1 mutation 3d disrupts exogenous antigen presentation and
RT   signaling via Toll-like receptors 3, 7 and 9.";
RL   Nat. Immunol. 7:156-164(2006).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, GLYCOSYLATION, AND INTERACTION WITH TLR3;
RP   TLR7; TLR9 AND TLR13.
RX   PubMed=17452530; DOI=10.1083/jcb.200612056;
RA   Brinkmann M.M., Spooner E., Hoebe K., Beutler B., Ploegh H.L., Kim Y.M.;
RT   "The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9
RT   is crucial for TLR signaling.";
RL   J. Cell Biol. 177:265-275(2007).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18305481; DOI=10.1038/nature06726;
RA   Kim Y.M., Brinkmann M.M., Paquet M.E., Ploegh H.L.;
RT   "UNC93B1 delivers nucleotide-sensing toll-like receptors to
RT   endolysosomes.";
RL   Nature 452:234-238(2008).
RN   [8]
RP   MUTAGENESIS OF ASP-34, AND INTERACTION WITH TLR7; TLR8 AND TLR13.
RX   PubMed=19451267; DOI=10.1084/jem.20082316;
RA   Fukui R., Saitoh S., Matsumoto F., Kozuka-Hata H., Oyama M., Tabeta K.,
RA   Beutler B., Miyake K.;
RT   "Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic
RT   cells toward DNA- but against RNA-sensing.";
RL   J. Exp. Med. 206:1339-1350(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Kidney, Lung, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [10] {ECO:0007744|PDB:7C77}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.30 ANGSTROMS) IN COMPLEX WITH TLR3,
RP   INTERACTION WITH TLR3, AND MUTAGENESIS OF PHE-133; TRP-137; PHE-140;
RP   ALA-147; LEU-148; SER-151; TYR-154; TRP-155; THR-160; ARG-281; SER-282;
RP   ILE-286; PHE-297 AND MET-300.
RX   PubMed=33432245; DOI=10.1038/s41594-020-00542-w;
RA   Ishida H., Asami J., Zhang Z., Nishizawa T., Shigematsu H., Ohto U.,
RA   Shimizu T.;
RT   "Cryo-EM structures of Toll-like receptors in complex with UNC93B1.";
RL   Nat. Struct. Mol. Biol. 28:173-180(2021).
CC   -!- FUNCTION: Plays an important role in innate and adaptive immunity by
CC       regulating nucleotide-sensing Toll-like receptor (TLR) signaling.
CC       Required for the transport of a subset of TLRs (including TLR3, TLR7
CC       and TLR9) from the endoplasmic reticulum to endolysosomes where they
CC       can engage pathogen nucleotides and activate signaling cascades. May
CC       play a role in autoreactive B-cells removal.
CC       {ECO:0000269|PubMed:16415873, ECO:0000269|PubMed:17452530,
CC       ECO:0000269|PubMed:18305481}.
CC   -!- SUBUNIT: Interacts with TLR3, TLR5, TLR7, TLR8, TLR9 and TLR13
CC       (probably via transmembrane domain). {ECO:0000269|PubMed:17452530,
CC       ECO:0000269|PubMed:19451267, ECO:0000269|PubMed:33432245}.
CC   -!- INTERACTION:
CC       Q8VCW4; O96005: CLPTM1; Xeno; NbExp=2; IntAct=EBI-6116986, EBI-2873194;
CC       Q8VCW4; P51617: IRAK1; Xeno; NbExp=2; IntAct=EBI-6116986, EBI-358664;
CC       Q8VCW4; Q96N66: MBOAT7; Xeno; NbExp=2; IntAct=EBI-6116986, EBI-6116499;
CC       Q8VCW4; O15260: SURF4; Xeno; NbExp=2; IntAct=EBI-6116986, EBI-1044848;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass
CC       membrane protein. Endosome. Lysosome. Cytoplasmic vesicle, phagosome.
CC       Note=Colocalizes with LAMP5 in large endosomal intracellular vesicles
CC       (By similarity). Relocalizes from endoplasmic reticulum to endosome and
CC       lysosome upon cell-stimulation with CpG dinucleotides. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8VCW4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8VCW4-2; Sequence=VSP_014036;
CC   -!- INDUCTION: Upon interleukin-4 treatment in B-cells.
CC       {ECO:0000269|PubMed:9798653}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:17452530}.
CC   -!- SIMILARITY: Belongs to the unc-93 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH25587.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK165060; BAE38019.1; -; mRNA.
DR   EMBL; BC018388; AAH18388.1; -; mRNA.
DR   EMBL; BC023731; AAH23731.1; -; mRNA.
DR   EMBL; BC025587; AAH25587.1; ALT_INIT; mRNA.
DR   EMBL; AJ422144; CAD19524.1; -; mRNA.
DR   EMBL; U89424; AAC36530.1; -; mRNA.
DR   CCDS; CCDS29404.2; -. [Q8VCW4-1]
DR   RefSeq; NP_001154900.1; NM_001161428.1.
DR   RefSeq; NP_062322.2; NM_019449.2.
DR   PDB; 7C77; EM; 3.30 A; B=1-598.
DR   PDBsum; 7C77; -.
DR   AlphaFoldDB; Q8VCW4; -.
DR   SMR; Q8VCW4; -.
DR   BioGRID; 207660; 2.
DR   IntAct; Q8VCW4; 27.
DR   STRING; 10090.ENSMUSP00000124272; -.
DR   GlyGen; Q8VCW4; 3 sites.
DR   iPTMnet; Q8VCW4; -.
DR   PhosphoSitePlus; Q8VCW4; -.
DR   SwissPalm; Q8VCW4; -.
DR   EPD; Q8VCW4; -.
DR   MaxQB; Q8VCW4; -.
DR   PaxDb; Q8VCW4; -.
DR   PeptideAtlas; Q8VCW4; -.
DR   PRIDE; Q8VCW4; -.
DR   ProteomicsDB; 300092; -. [Q8VCW4-1]
DR   ProteomicsDB; 300093; -. [Q8VCW4-2]
DR   DNASU; 54445; -.
DR   GeneID; 54445; -.
DR   KEGG; mmu:54445; -.
DR   UCSC; uc008fxt.1; mouse. [Q8VCW4-1]
DR   CTD; 81622; -.
DR   MGI; MGI:1859307; Unc93b1.
DR   eggNOG; KOG3097; Eukaryota.
DR   InParanoid; Q8VCW4; -.
DR   OrthoDB; 394901at2759; -.
DR   Reactome; R-MMU-1679131; Trafficking and processing of endosomal TLR.
DR   BioGRID-ORCS; 54445; 4 hits in 74 CRISPR screens.
DR   ChiTaRS; Unc93b1; mouse.
DR   PRO; PR:Q8VCW4; -.
DR   Proteomes; UP000000589; Unplaced.
DR   RNAct; Q8VCW4; protein.
DR   GO; GO:0032009; C:early phagosome; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005768; C:endosome; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0035325; F:Toll-like receptor binding; IPI:UniProtKB.
DR   GO; GO:0019882; P:antigen processing and presentation; IMP:MGI.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; IMP:MGI.
DR   GO; GO:0000902; P:cell morphogenesis; IMP:MGI.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0006886; P:intracellular protein transport; IMP:UniProtKB.
DR   GO; GO:0032735; P:positive regulation of interleukin-12 production; IMP:MGI.
DR   GO; GO:0032755; P:positive regulation of interleukin-6 production; IMP:MGI.
DR   GO; GO:0002457; P:T cell antigen processing and presentation; IMP:MGI.
DR   GO; GO:0034138; P:toll-like receptor 3 signaling pathway; IMP:UniProtKB.
DR   GO; GO:0034154; P:toll-like receptor 7 signaling pathway; IMP:UniProtKB.
DR   GO; GO:0034162; P:toll-like receptor 9 signaling pathway; IMP:UniProtKB.
DR   GO; GO:0002224; P:toll-like receptor signaling pathway; IMP:MGI.
DR   InterPro; IPR010291; Ion_channel_UNC-93.
DR   InterPro; IPR043268; UNC93B1.
DR   PANTHER; PTHR46744; PTHR46744; 1.
DR   Pfam; PF05978; UNC-93; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Alternative splicing; Antiviral defense;
KW   Cytoplasmic vesicle; Endoplasmic reticulum; Endosome; Glycoprotein;
KW   Immunity; Innate immunity; Lysosome; Membrane; Phosphoprotein;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..598
FT                   /note="Protein unc-93 homolog B1"
FT                   /id="PRO_0000190041"
FT   TRANSMEM        64..84
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        110..130
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        132..152
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        160..180
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        223..243
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        285..305
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        343..363
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        378..398
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        403..423
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        428..448
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        469..489
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        495..515
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   REGION          1..36
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          524..598
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        546..560
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         547
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H1C4"
FT   MOD_RES         550
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H1C4"
FT   CARBOHYD        251
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        272
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        449
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..292
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_014036"
FT   MUTAGEN         34
FT                   /note="D->A: Increases the TLR7 response and decreases the
FT                   TLR9 response. Enhances interaction with TLR7, TLR8 and
FT                   TLR13 and TLR7 transport to endolysosomes in presence of
FT                   single-stranded RNA. Decreases affinity for TLR9 and its
FT                   transport to endolysosomes in presence of DNA."
FT                   /evidence="ECO:0000269|PubMed:19451267"
FT   MUTAGEN         36
FT                   /note="L->A: Increases the TLR7 response and decreases the
FT                   TLR9 response."
FT   MUTAGEN         133
FT                   /note="F->A,W: No effect on interaction with TLR3."
FT                   /evidence="ECO:0000269|PubMed:33432245"
FT   MUTAGEN         137
FT                   /note="W->A: No effect on interaction with TLR3."
FT                   /evidence="ECO:0000269|PubMed:33432245"
FT   MUTAGEN         140
FT                   /note="F->A: Decreases interaction with TLR3."
FT                   /evidence="ECO:0000269|PubMed:33432245"
FT   MUTAGEN         140
FT                   /note="F->W: Increases interaction with TLR3."
FT                   /evidence="ECO:0000269|PubMed:33432245"
FT   MUTAGEN         147
FT                   /note="A->W: Decreases interaction with TLR3."
FT                   /evidence="ECO:0000269|PubMed:33432245"
FT   MUTAGEN         148
FT                   /note="L->A: No effect on interaction with TLR3."
FT                   /evidence="ECO:0000269|PubMed:33432245"
FT   MUTAGEN         148
FT                   /note="L->W: Increases interaction with TLR3."
FT                   /evidence="ECO:0000269|PubMed:33432245"
FT   MUTAGEN         151
FT                   /note="S->A,W: Strongly decreases interaction with TLR3."
FT                   /evidence="ECO:0000269|PubMed:33432245"
FT   MUTAGEN         154
FT                   /note="Y->A,W: Strongly decreases interaction with TLR3."
FT                   /evidence="ECO:0000269|PubMed:33432245"
FT   MUTAGEN         155
FT                   /note="W->A: Decreases interaction with TLR3."
FT                   /evidence="ECO:0000269|PubMed:33432245"
FT   MUTAGEN         160
FT                   /note="T->A,W: Decreases interaction with TLR3."
FT                   /evidence="ECO:0000269|PubMed:33432245"
FT   MUTAGEN         281
FT                   /note="R->A: Strongly decreases interaction with TLR3."
FT                   /evidence="ECO:0000269|PubMed:33432245"
FT   MUTAGEN         281
FT                   /note="R->W: No effect on interaction with TLR3."
FT                   /evidence="ECO:0000269|PubMed:33432245"
FT   MUTAGEN         282
FT                   /note="S->W: No effect on interaction with TLR3."
FT                   /evidence="ECO:0000269|PubMed:33432245"
FT   MUTAGEN         286
FT                   /note="I->A,W: No effect on interaction with TLR3."
FT                   /evidence="ECO:0000269|PubMed:33432245"
FT   MUTAGEN         297
FT                   /note="F->W: No effect on interaction with TLR3."
FT                   /evidence="ECO:0000269|PubMed:33432245"
FT   MUTAGEN         300
FT                   /note="M->A,W: No effect on interaction with TLR3."
FT                   /evidence="ECO:0000269|PubMed:33432245"
FT   MUTAGEN         412
FT                   /note="H->R: Loss of function in TLR signaling. Impaired in
FT                   its own transport from endoplasmic reticulum to endosome,
FT                   lysosome and phagosome. Loss of the interaction with TLR3,
FT                   TLR7, TLR9 and TLR13 and of the ability to transport them
FT                   to endolysosome."
FT                   /evidence="ECO:0000269|PubMed:16415873"
FT   CONFLICT        325..326
FT                   /note="GN -> RS (in Ref. 4; AAC36530)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        338
FT                   /note="F -> S (in Ref. 4; AAC36530)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        347
FT                   /note="F -> L (in Ref. 4; AAC36530)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        380
FT                   /note="I -> T (in Ref. 4; AAC36530)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        401..403
FT                   /note="RSV -> HSA (in Ref. 4; AAC36530)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        574
FT                   /note="A -> T (in Ref. 2; AAH18388/AAH23731/AAH25587)"
FT                   /evidence="ECO:0000305"
FT   HELIX           47..88
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   STRAND          90..92
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   HELIX           93..96
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   TURN            97..99
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   HELIX           104..117
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   HELIX           119..124
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   HELIX           127..133
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   HELIX           135..151
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   TURN            152..155
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   HELIX           158..198
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   STRAND          200..203
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   HELIX           214..234
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   HELIX           237..241
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   TURN            242..245
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   HELIX           250..253
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   TURN            254..256
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   STRAND          265..270
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   STRAND          276..278
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   HELIX           282..306
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   HELIX           313..320
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   STRAND          324..326
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   TURN            327..329
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   HELIX           330..333
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   HELIX           334..336
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   HELIX           340..358
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   TURN            359..367
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   STRAND          368..370
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   HELIX           375..394
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   TURN            395..397
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   HELIX           404..418
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   HELIX           433..460
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   HELIX           464..487
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   HELIX           495..516
FT                   /evidence="ECO:0007829|PDB:7C77"
FT   TURN            517..519
FT                   /evidence="ECO:0007829|PDB:7C77"
SQ   SEQUENCE   598 AA;  66981 MW;  E0E8AC1C3BBD9E10 CRC64;
     MEVEPPLYPV AGAAGPQGDE DRHGVPDGPE APLDELVGAY PNYNEEEEER RYYRRKRLGV
     VKNVLAASTG VTLTYGVYLG LLQMQLILHY DETYREVKYG NMGLPDIDSK MLMGINVTPI
     AALLYTPVLI RFFGTKWMMF LAVGIYALFV STNYWERYYT LVPSAVALGM AIVPLWASMG
     NYITRMSQKY YEYSHYKEQD EQGPQQRPPR GSHAPYLLVF QAIFYSFFHL SFACAQLPMI
     YFLNNYLYDL NHTLINVQSC GTKSQGILNG FNKTVLRTLP RSKNLIVVES VLMAVAFLAM
     LMVLGLCGAA YRPTEEIDLR SVGWGNIFQL PFKHVRDFRL RHLVPFFIYS GFEVLFACTG
     FALGYGVCSM GLERLAYLLI AYSLGASASS VLGLLGLWLP RSVPLVAGAG LHLLLTLSLF
     FWAPAPRVLQ HSWIFYFVAA LWGVGSALNK TGLSTLLGIL YEDKERQDFI FTIYHWWQAV
     AIFVVYLGSS LPMKAKLAVL LVTLVAAAAS YLWMEQKLQQ GLVPRQPRIP KPQHKVRGYR
     YLEEDNSDES DMEGEQGQGD CAEDEAPQAG PLGAEPAGPC RKPCPYEQAL GGDGPEEQ
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024